Lilly to participate in J.P. Morgan Healthcare Conference
Eli Lilly (NYSE: LLY) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16, 2025. The company's chair and CEO, David A. Ricks, will engage in a fireside chat on Tuesday, January 14 at 5:15 p.m. Eastern time.
The event will be accessible through a live audio webcast on Lilly's Investor website under the 'Webcasts & Presentations' section. Investors and interested parties can access the replay of the presentation on the same platform for approximately 30 days following the event.
Eli Lilly (NYSE: LLY) ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference, in programma dal 13 al 16 gennaio 2025. Il presidente e CEO dell'azienda, David A. Ricks, parteciperà a una chiacchierata informale martedì 14 gennaio alle 17:15 ora orientale.
L'evento sarà accessibile tramite un webcast audio dal vivo sul sito web per investitori di Lilly nella sezione 'Webcasts & Presentations'. Gli investitori e le parti interessate potranno accedere alla registrazione della presentazione sulla stessa piattaforma per circa 30 giorni dopo l'evento.
Eli Lilly (NYSE: LLY) ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan, programada para el 13 al 16 de enero de 2025. El presidente y CEO de la compañía, David A. Ricks, participará en una charla informal el martes 14 de enero a las 5:15 p.m. hora del Este.
El evento será accesible a través de un webcast de audio en vivo en el sitio web para inversores de Lilly en la sección 'Webcasts & Presentations'. Los inversores y partes interesadas podrán acceder a la repetición de la presentación en la misma plataforma durante aproximadamente 30 días después del evento.
엘리 릴리 (NYSE: LLY)은 제43차 JP모르간 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 이 컨퍼런스는 2025년 1월 13일부터 16일 사이에 열릴 예정입니다. 회사의 회장 겸 CEO인 데이비드 A. 릭스는 1월 14일 화요일 오후 5시 15분(동부 표준시)에 대담 형식의 대화에 참여할 것입니다.
이번 이벤트는 실시간 오디오 웹캐스트를 통해 릴리의 투자자 웹사이트 'Webcasts & Presentations' 섹션에서 접근 가능합니다. 투자자 및 관심 있는 분들은 이벤트 이후 약 30일 동안 같은 플랫폼에서 발표 리플레이에 접근할 수 있습니다.
Eli Lilly (NYSE: LLY) a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare, prévue du 13 au 16 janvier 2025. Le président et PDG de la société, David A. Ricks, participera à une discussion informelle le mardi 14 janvier à 17h15, heure de l'Est.
L'événement sera accessible via un webcast audio en direct sur le site Web des investisseurs de Lilly dans la section 'Webcasts & Presentations'. Les investisseurs et les parties intéressées pourront accéder à la rediffusion de la présentation sur la même plateforme pendant environ 30 jours après l'événement.
Eli Lilly (NYSE: LLY) hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference angekündigt, die vom 13. bis 16. Januar 2025 stattfinden wird. Der Vorsitzende und CEO des Unternehmens, David A. Ricks, wird am Dienstag, den 14. Januar um 17:15 Uhr Eastern Time an einem informellen Gespräch teilnehmen.
Die Veranstaltung wird über einen Live-Audio-Webcast auf der Investoren-Website von Lilly im Abschnitt 'Webcasts & Presentations' zugänglich sein. Investoren und interessierte Parteien können die Wiederholung der Präsentation auf derselben Plattform etwa 30 Tage nach der Veranstaltung abrufen.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 30 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Refer to: | Carrie Munk; munk_carrie@lilly.com; 317-416-2393 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-jp-morgan-healthcare-conference-302343425.html
SOURCE Eli Lilly and Company
FAQ
When is Eli Lilly (LLY) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Eli Lilly's (LLY) J.P. Morgan Healthcare Conference presentation?
How long will the replay of LLY's 2025 J.P. Morgan Healthcare presentation be available?
Who will represent Eli Lilly (LLY) at the 2025 J.P. Morgan Healthcare Conference?
